The progress in understanding and treatment of diabetic retinopathy

AW Stitt, TM Curtis, M Chen, RJ Medina… - Progress in retinal and …, 2016 - Elsevier
Diabetic retinopathy is the most frequently occurring complication of diabetes mellitus and
remains a leading cause of vision loss globally. Its aetiology and pathology have been …

Diabetic macular edema: evidence-based management

DJ Browning, MW Stewart, C Lee - Indian journal of …, 2018 - journals.lww.com
Diabetic macular edema (DME) is the most common cause of vision loss in patients with
diabetic retinopathy with an increasing prevalence tied to the global epidemic in type 2 …

[HTML][HTML] Ocular complications of diabetes mellitus

N Sayin, N Kara, G Pekel - World journal of diabetes, 2015 - ncbi.nlm.nih.gov
Diabetes mellitus (DM) is a important health problem that induces ernestful complications
and it causes significant morbidity owing to specific microvascular complications such as …

Diabetic retinopathy, a vascular and inflammatory disease: therapeutic implications

F Semeraro, F Morescalchi, A Cancarini, A Russo… - Diabetes & …, 2019 - Elsevier
Diabetic retinopathy (DR) is the most common microvascular complication of diabetes and
the leading cause of visual impairment in the working-age population in the Western world …

Biocompatible materials for continuous glucose monitoring devices

SP Nichols, A Koh, WL Storm, JH Shin… - Chemical …, 2013 - ACS Publications
Diabetes mellitus is a worldwide epidemic characterized by chronic hyperglycemia that
results from either a deficiency or tolerance in insulin. 1 In the United States, 8.3% of the …

The role of inflammation and therapeutic concepts in diabetic retinopathy—a short review

K Gomułka, M Ruta - International Journal of Molecular Sciences, 2023 - mdpi.com
Diabetic retinopathy (DR) as a microangiopathy is the most common complication in patients
with diabetes mellitus (DM) and remains the leading cause of blindness among adult …

Association of vitreous inflammatory factors with diabetic macular edema

H Funatsu, H Noma, T Mimura, S Eguchi, S Hori - Ophthalmology, 2009 - Elsevier
PURPOSE: To evaluate the association between vitreous inflammatory factors and the
severity of diabetic macular edema (DME). DESIGN: Retrospective case-control study …

Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy

R Simo, E Carrasco, M Garcia-Ramirez… - Current diabetes …, 2006 - ingentaconnect.com
Diabetic retinopathy continues to be the leading cause of legal blindness among working-
age individuals. The earliest histological features of diabetic retinopathy include neuroretinal …

Vascular endothelial growth factor in the lung

NF Voelkel, RW Vandivier… - American Journal of …, 2006 - journals.physiology.org
Vascular endothelial growth factor (VEGF) is a pluripotent growth and permeability factor
that has a broad impact on endothelial cell function. The lung tissue is very rich in this …

Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema

JA Haller, BD Kuppermann… - Archives of …, 2010 - jamanetwork.com
Objective To evaluate the safety and efficacy of a dexamethasone intravitreous drug delivery
system (DDS) in eyes with diabetic macular edema (DME). Methods Patients with persistent …